Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Selvita
Selvita
Activities:
Research & Development
X
LinkedIn
Trending Articles
Optimising RNA production for faster and cheaper pharmaceutical manufacturing
RNA production can be a lengthy and complex process, but the Ntensify platform could change this by diminishing development times, decreasing production costs and allowing the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Owlstone Medical bags $6.5m to optimise infectious disease diagnostic tool
The Bill & Melinda Gates Foundation has funded the bolstering of the Breath Biopsy platform, as well as research into breath biomarkers in tuberculosis (TB) and HIV
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Recruitment
Selvita appoints Dr Steffen Heeger as Chief Medical Officer
Research & Development
Selvita promotes Edyta Jaworska to its management board
Research & Development
Epidarex Capital creates Nodthera Limited
A pioneering new company based on Selvita research and utilising novel immunological approaches to disease
Design & Build
Selvita opens new research site in Poznan, Poland
Will initially employ around 50 chemist and biologists
Research & Development
Merck and Selvita enter new drug discovery collaboration
With the aim of discovering small molecule lead candidates for multiple oncology indications
Finance
Selvita launches new company
Ardigen will focus on bioinformatics and personalised medicine
Research & Development
Selvita establishes UK subsidiary in Cambridge
To be closer to business partners located in the UK
Subscribe now